마이크로캐리어 시장 규모, 점유율, 동향 분석 보고서 : 소모품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Microcarriers Market Size, Share & Trends Analysis Report By Consumable (Media & Reagents, Microcarrier Beads), By Application (Biopharmaceutical Production, Regenerative Medicine), By End Use, By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,626,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,076,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,976,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

마이크로캐리어 시장 개요

세계의 마이크로캐리어 시장 규모는 2025년에 21억 3,000만 달러로 추정되며, 2033년에 48억 9,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 성장률(CAGR)은 11.18%로 예상됩니다. 마이크로캐리어 산업의 성장은 세포 기반 백신 및 치료에 대한 높은 수요, 당뇨병, 암, 류마티스 관절염, 혈우병 등 다양한 질병 및 장애의 발생률 증가, 혁신적인 치료법 개발을 위한 막대한 투자, 그리고 세포 생물학 연구의 꾸준한 기술 발전에 기인합니다.

예를 들어, 2024년 5월 Sartorius와 사노피는 협력하여 다운스트림 공정의 바이오프로세스 운영을 간소화하고 최적화하는 플랫폼을 개발 및 상용화하기 위해 협력하고 있습니다. 이를 통해 바이오의약품의 생산 효율과 생산성을 향상시키고, 보다 고도화된 마이크로캐리어 기반 바이오공정 기술 개발로 이어질 수 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 마이크로캐리어 시장의 변수, 동향과 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련·보조 시장 전망
• 시장 역학
• 산업 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석

제4장 마이크로캐리어 시장 : 소모품별, 추정·동향 분석

• 소모품별 변동 분석과 시장 점유율(2025년과 2033년)
• 마이크로캐리어 시장 추정·예측 : 소모품별, 2021-2033년
• 배지와 시약
• 마이크로캐리어 비즈
  • 콜라겐 피복 비즈
  • 양이온성 비즈
  • 단백질 코팅 비즈
  • 미처리 비즈
  • 기타

제5장 마이크로캐리어 시장 : 용도별, 추정·동향 분석

• 용도별 변동 분석과 시장 점유율(2025년과 2033년)
• 마이크로캐리어 시장 추정·예측 : 용도별, 2021-2033년
• 바이오의약품 제조
  • 백신 생산
  • 치료 생산
• 재생의료

제6장 마이크로캐리어 시장 : 최종 용도별, 추정·동향 분석

• 최종 용도별 변동 분석과 시장 점유율(2025년과 2033년)
• 마이크로캐리어 시장 추정·예측 : 최종 용도별, 2021-2033년
• 제약 바이오테크놀러지 기업
• 수탁연구기관(CRO)과 위탁생산(CMO)
• 학술·연구기관

제7장 마이크로캐리어 시장 : 지역별, 추정·동향 분석(소모품·용도·최종 용도별)

• 지역별 대시보드
• 시장 규모, 예측, 동향 분석, 2021-2033년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 기업/경쟁 분류
• 주요 기업의 시장 포지션 분석(2025년)
• 기업 개요
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Sartorius AG
  • Corning Incorporated
  • Eppendorf SE
  • Bio-Rad Laboratories, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • DenovoMATRIX GmbH

KSM

영문 목차

영문목차

Microcarriers Market Summary

The global microcarriers market size was estimated at USD 2.13 billion in 2025 and is projected to reach USD 4.89 billion by 2033, growing at a CAGR of 11.18% from 2026 to 2033. The growth of the microcarriers industry is attributed to the high demand for cell-based vaccines & therapeutics, the increasing incidence of various diseases & disorders such as diabetes, cancer, rheumatoid arthritis, hemophilia, and others, huge investments for the development of innovative therapies, and consistent technological advancements in cell biology research.

For instance, in May 2024, Sartorius and Sanofi partnered to develop and commercialize a platform that streamlines and optimizes downstream bioprocessing operations, enhancing efficiency and productivity in the production of biopharmaceuticals. This can lead to the development of more sophisticated microcarrier-based bioprocessing technologies.

Global Microcarriers Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global microcarriers market report based on the consumable, application, end use, and region:

• Consumable Outlook (Revenue, USD Million, 2021 - 2033)
• Media & Reagents
• Microcarrier Beads
  • Collagen Coated Beads
  • Cationic Beads
  • Protein Coated Beads
  • Untreated Beads
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
  • Vaccine Production
  • Therapeutic Production
• Regenerative Medicine
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definition
  • 1.2.1. Consumable
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
• 1.7. Primary Research
• 1.8. Information or Data Analysis
• 1.9. Market Formulation & Validation
• 1.10. Market Model
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Microcarriers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High demand of cell-based vaccines & therapeutics
    • 3.2.1.2. Rising incidence of chronic diseases & disorders
    • 3.2.1.3. Increasing investments for development of innovative therapies
    • 3.2.1.4. Recent technological advancements in cell biology research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of research for cell based drug and therapy
    • 3.2.2.2. High cost of downstream processing
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Microcarriers Market: Consumable Estimates & Trend Analysis

• 4.1. Consumable Movement Analysis & Market Share, 2025 & 2033
• 4.2. Microcarriers Market Estimates & Forecast, By Consumable, 2021 to 2033 (USD Million)
• 4.3. Media and Reagents
  • 4.3.1. Media and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Microcarrier Beads
  • 4.4.1. Microcarrier Beads Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Collagen Coated Beads
    • 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Cationic Beads
    • 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Protein Coated Beads
    • 4.4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Untreated Beads
    • 4.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Others
    • 4.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Microcarriers Market: Application Estimates & Trend Analysis

• 5.1. Application Movement Analysis & Market Share, 2025 & 2033
• 5.2. Microcarriers Market Estimates & Forecast, By Application, 2021 to 2033 (USD Million)
• 5.3. Biopharmaceutical Production
  • 5.3.1. Biopharmaceutical Production Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Vaccine Production
    • 5.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Therapeutic Production
    • 5.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Regenerative Medicine
  • 5.4.1. Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Microcarriers Market: End Use Estimates & Trend Analysis

• 6.1. End Use Movement Analysis & Market Share, 2025 & 2033
• 6.2. Microcarriers Market Estimates & Forecast, By End Use, 2021 to 2033 (USD Million)
• 6.3. Pharmaceutical & Biotechnology Companies
  • 6.3.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Contract Research Organizations (CRO)s & Contract Manufacturing Organizations (CMO)s
  • 6.4.1. CROs & CMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Microcarriers Market: Regional Estimates & Trend Analysis by Consumable, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.3. North America
  • 7.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Key company market position analysis, 2025
• 8.3. Company Overview
  • 8.3.1. Thermo Fisher Scientific, Inc.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Merck KGaA
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Danaher Corporation
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Sartorius AG
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Corning Incorporated
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Eppendorf SE
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Bio-Rad Laboratories, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. HiMedia Laboratories Pvt. Ltd.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. DenovoMATRIX GmbH
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives

관련자료